LoginRegister

    Hikal Gujarat facility gets EIR from USFDA

    Farhat NasimWritten by Farhat Nasim   |  

    The pharmaceutical manufacturing facility at Panoli in Gujarat was recently inspected by the US Food and Drug Administration (USFDA) in compliance with their requirements.


    New Delhi: Drug firm, Hikal recently announced that the US Health regulator has issued an Establishment Inspection Report (EIR) for its facility at Panoli, Gujarat.


    The pharmaceutical manufacturing facility at Panoli in Gujarat was recently inspected by the US Food and Drug Administration (USFDA) in compliance with their requirements.


    The five-day detailed inspection was carried out during the period September 9-13 this year, the company said in its BSE filing.


    Also Read: Hikal up 11 pc on successful USFDA inspection




    The inspection confirmed the site to be compliant with the principles and guidelines of Current Good Manufacturing Practices (CGMP), it added.


    The inspection concluded with 'zero' 483 observations from auditors. "The EIR received today has classified the facility under NAI (No Action Indicated) for CGMP compliance, " Hikal said.


    cGMPEIREstablishment Inspection ReportHikalhikal gujarat facilityhikal inspectionnaiNo Action IndicatedpharmaPharma companiespharma newsUSUSFDAusfda 483USFDA observations

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X